12.8. Scope of consolidation

Initial consolidation

The initial consolidation of UREM Polska Sp.z.o.o (formerly GD&K Consulting Sp.z o.o.) (Poland, Krakow) took place in the second quarter of 2025.

Mavie Med Ambulant GmbH (Vienna) was established with the entry in the commercial register on 22 November 2025 and was included in the scope of consolidation for the first time in the fourth quarter. All of Mavie Med Group’s outpatient medical care business lines are to be combined and further developed in this company.

Restructuring processes

UNIQA Beteiligungs-Holding GmbH (Vienna) was merged into UNIQA Österreich Versicherungen AG (Vienna) with retroactive effect from 31 December 2024 by entry in the commercial register on 21 June 2025 and is therefore no longer included in the scope of consolidation.

Business combinations

Mavie Med Wörgl Private Hospital

On 31 January 2025, 100 per cent of the shares in Mavie Med Privatklinik Wörgl GmbH (formerly Kursana Gesundheitszentrum Wörgl BetriebsgmbH) (Vienna) were acquired. The aim of the acquisition was to broaden UNIQA’s product portfolio and strengthen its market position in health insurance. The company is recognised in the Group functions segment and in the health insurance business line.

In the consolidated financial statements, revenue amounting to €6,597 thousand and a positive earnings contribution of €1,465 thousand were recognised from this acquisition.

The transaction costs amounted to €116 thousand and are presented in other non-insurance service expenses.

Assessment Systems Group

On 21 July 2025, 100 per cent of the shares in Assessment Systems CEE Holding a.s. (Czechia, Prague), a leading provider of occupational health promotion services, were acquired. The acquisition comprises the holding company and its holdings Assessment Systems Adria d.o.o. (Serbia, Subotica), Assessment Systems Hungary Kft. (Hungary, Budapest), Assessment Systems International s.r.o. (Czechia, Prague), Assessment Systems Poland Sp. z o.o. (Poland, Warsaw), Assessment Systems Slovakia s.r.o. (Slovakia, Bratislava) and Assessment Systems s.r.o. (Czechia, Prague). The companies are recognised in the Group functions segment and in the health insurance business line.

Revenue of €2,501 thousand and a positive contribution to earnings of around €49 thousand are recognised in the consolidated financial statements from the acquisition. If the acquisition had already taken place on 1 January 2025, profit/(loss) for the period (the share attributable to the shareholders of UNIQA Insurance Group AG) would amount to €424,707 thousand and earnings per share would remain unchanged due to the low earnings contribution.

The transaction costs amounted to €356 thousand and are presented in other non-technical expenses.

uLékaře

On 10 December 2025, 70 per cent of the shares in uLékaře.cz, s.r.o, (Czechia, Prague) and its wholly owned subsidiaries uLékaře.cz Health Care, s.r.o (Czechia, Prague) and Soulody.com, s.r.o (Slovakia, Bratislava) were acquired. This group of companies is a leading health tech enterprise focusing on digital health services for companies in Czechia and Slovakia. The companies are recognised in the Group functions segment and in the health insurance business line.

Option agreements for the acquisition of the remaining 30 per cent were entered into with the remaining two shareholders with an exercise period of two and four years, respectively, after which the capital shares can be acquired in accordance with an agreed purchase price formula. However, the structure of this formula means that there is 100 per cent inclusion in the consolidated financial statements, with no non-controlling interests to be recognised. Part of the resulting future payments must be treated as a purchase price component and part is recognised as a current expense in the exercise period.

If the acquisition had already taken place on 1 January 2025, profit/(loss) for the period (the share attributable to the shareholders of UNIQA Insurance Group AG) would amount to €424,930 thousand and earnings per share would remain unchanged due to the low earnings contribution.

The transaction costs amounted to €172 thousand and are presented in other non-technical expenses.

Wellbeing Polska

On 17 December 2025, 100 per cent of the shares in Health Networks Sp. z o.o.(Poland, Krakow), a technology-driven provider in the digital health and IT sector with a focus on software development, data management and digital health solutions in Poland, were acquired.

The company is recognised in the Group functions segment in the health insurance business line.

If the acquisition had already taken place on 1 January 2025, profit/(loss) for the period (the share attributable to the shareholders of UNIQA Insurance Group AG) would amount to €424,956 thousand and earnings per share would remain unchanged due to the low earnings contribution.

The transaction costs amounted to €218 thousand and are presented in other non-technical expenses.

Capital increases

In the second quarter of 2025, there was a capital increase at Mavie Next GmbH (Vienna) in which UNIQA did not participate. This resulted in a 25.1 per cent dilution of the shares. The earnings contribution of Mavie Next GmbH and its subsidiaries is accordingly allocated to non-controlling interests.

Disposals

In the second quarter of 2025, SIGAL UNIQA Group AUSTRIA sh.a. (Albania, Tirana) including its subsidiaries SIGAL LIFE UNIQA Group AUSTRIA sh.a. (Albania, Tirana), SIGAL UNIQA Group AUSTRIA sh.a. (Kosovo, Pristina), SIGAL LIFE UNIQA Group AUSTRIA sh.a. (Kosovo, Pristina), UNIQA AD Skopje (North Macedonia, Skopje) and UNIQA Life AD Skopje (North Macedonia, Skopje) was deconsolidated.